Emergency Care Action Plans for Infants with Medical Complexity
Launched by UNIVERSITY OF VERMONT · May 30, 2024
Trial Information
Current as of May 18, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
National expert recommendations and human-centered design principles were used to optimize an Emergency Care Action Plan (ECAP) for infants with medical complexity. This study will implement and monitor the effectiveness and feasibility of the optimized Emergency Care Action Plan for infants with medical complexity. The primary objective is to determine the effectiveness of a user-centered Emergency Care Action Plan for infants with medical complexity on emergency health care utilization and cost metrics. The secondary objective is to monitor and evaluate barriers and facilitators to the cu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 0 to 6 months
- • Admitted to the University of Vermont Medical Center Neonatal Intensive Care Unit (NICU)
- • Meets or is expected to meet Children with Medical Complexity status as determined by the treating NICU clinician and defined as "children with multiple significant chronic health problems including multiple organ systems, which result in functional limitations, high health care needs or utilization, and often require need for, or use of, medical technology."
- Exclusion Criteria:
- • Does not have a caregiver participant who agrees to their participation in the study to complete follow-up surveys
- • Does not intend to use University of Vermont Health Network and affiliated sites for care during the one-year trial period
About University Of Vermont
The University of Vermont (UVM) is a leading academic institution known for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UVM leverages its diverse expertise in medicine, public health, and biomedical sciences to conduct cutting-edge clinical studies. The university aims to translate scientific findings into effective treatments and interventions, ultimately improving patient outcomes and contributing to the broader medical community. UVM's research facilities and access to a wide patient population support its mission to foster a culture of inquiry and excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Burlington, Vermont, United States
Patients applied
Trial Officials
Christian D Pulcini, MD, MEd, MPH
Principal Investigator
University of Vermont Larner College of Medicine, University of Vermont Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported